Codes / ICD10CM / D07.0

D07.0 Carcinoma in situ of endometrium

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Carcinoma in situ of endometrium
  • Also known as non-invasive cancer of the uterine lining.

Summary

Carcinoma in situ of the endometrium refers to early-stage, non-invasive tumors confined to the lining cells of the uterus. The abnormal cells have not invaded deeper tissues or spread to other parts of the body, but they have the potential to progress to invasive cancer if left untreated.

Causes

The exact causes of carcinoma in situ in the endometrium are not fully understood, but they may involve DNA mutations in the lining cells. Prolonged exposure to estrogen without progesterone, and chronic irritation are believed to contribute to the development of these lesions.

Risk Factors

  • Unopposed estrogen exposure (e.g., hormone therapy without progesterone)
  • Obesity
  • Diabetes
  • Age (more common in older adults)
  • Family history of endometrial or colorectal cancer
  • Nulliparity (never having given birth)
  • Tamoxifen use

Symptoms

  • Often asymptomatic in early stages
  • Abnormal uterine bleeding (e.g., postmenopausal bleeding)
  • Unusual vaginal discharge
  • Pelvic pain or pressure

Diagnosis

Diagnosis typically involves endometrial biopsy or dilation and curettage (D&C) to examine tissue samples for atypical cells. Imaging studies such as transvaginal ultrasound may be used to assess the uterine lining.

Treatment Options

  • Hysterectomy (surgical removal of the uterus)
  • Progestin therapy (hormonal treatment)
  • Endometrial ablation (destruction of the uterine lining)
  • Close monitoring with regular biopsies

Prognosis and Follow-Up

Prognosis is generally favorable when treated early, as carcinoma in situ is non-invasive. Follow-up care may include regular pelvic exams, imaging, or biopsies to monitor for recurrence or progression.

Complications

  • Progression to invasive endometrial cancer
  • Recurrence of abnormal cells
  • Surgical or treatment-related side effects (e.g., infertility, menopausal symptoms)

Lifestyle & Prevention

  • Maintain a healthy weight
  • Manage diabetes and blood pressure
  • Discuss hormone therapy risks with a healthcare provider
  • Consider genetic counseling if there is a family history of related cancers

When to Seek Professional Help

Seek medical attention for abnormal uterine bleeding, especially postmenopausal bleeding, or persistent pelvic pain. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Document the specific location (endometrium) and confirm the diagnosis as carcinoma in situ. Ensure clinical documentation supports the absence of invasion or metastasis, as this distinguishes it from invasive cancer.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

D07.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.